T cell immune responses following vaccination with mRNA BNT162b2 against SARS-CoV-2 in patients with chronic lymphocytic leukemia: results from a prospective open-label clinical trial.

JSON

Blixt L, Wullimann D, Aleman S, Lundin J, Chen P, Gao Y, Cuapio A, Akber M, Lange J, Rivera-Ballesteros O, Buggert M, Ljunggren H, Hansson L, Österborg A

Haematologica - (-) - [2022-01-20; online 2022-01-20]

Not available.

Category: Biochemistry

Category: Health

Category: Vaccines

Funder: KAW/SciLifeLab National COVID program

Funder: VR

Research Area: Vaccine

Type: Journal article

PubMed 35045694

DOI 10.3324/haematol.2021.280300

Crossref 10.3324/haematol.2021.280300